TCL Archive OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds April 22, 1983
TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says November 28, 2014
TCL Archive Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough? December 14, 2007
TCL Archive In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named June 5, 1981
